IGF1R and type 2 diabetes mellitus: MKR mice are a model of non-obese Type 2 diabetes created by engineering a muscle-specific dominant-negative insulin-like growth factor-1 receptor (IGF-1R) transgene that abrogates IGF-1R and insulin receptor (IR) function in skeletal muscle by forming hybrids exclusively with endogenous muscle IGF-1Rs [1].